EU Approves Adcetris for Certain Types of Cutaneous T-cell Lymphoma
News
The European Commission has approved Adcetris (brentuximab vedotin) as a treatment for adults with cutaneous T-cell lymphoma (CTCL) whose cancer produces the CD30 molecule. It had previously given the therapy ... Read more